Rapid and accurate identification of bacterial infections and their resistance to antibiotics is critical to effective clinical decision-making and combating antimicrobial resistance. However, current diagnostic approaches are typically segmented: te...
Ocrelizumab and natalizumab are commonly prescribed high-effectiveness disease-modifying therapies (DMTs) for relapsing-remitting multiple sclerosis (RRMS). However, no randomized clinical trial and few real-world studies have directly compared their...
Immunotherapy has improved outcomes in non-small cell lung cancer (NSCLC), but only a subset of patients achieves durable survival benefit. Conventional biomarkers such as PD-L1 expressions have limited predictive power. This study aimed to develop a...
Colorectal cancer (CRC) exhibits marked heterogeneity across age, ancestry, and treatment context, underscored by the rising incidence of early-onset disease (EOCRC). The mitogen-activated protein kinase (MAPK) signaling axis is a central regulator o...
Diabetes mellitus remains a major global health burden, causing an estimated 3.4 million deaths in 2024 and highlighting the need for accurate early identification of individuals at risk of developing type 2 diabetes (T2D). Electronic health records ...
Large language models (LLMs) have shown incredible promise in medicine. While LLMs may be particularly useful in areas requiring extensive review of clinical records, their use remains limited due to their tendency to hallucinate and fabricate inform...
Large pretrained models developed and shared by actors with privileged access to data and compute have played a central role in the democratisation of deep learning in a range of domains. Here, we contribute to this endeavour in the field of neuroima...
Parkinson’s Disease (PD) is the most prevalent neurodegenerative disorder after Alzheimer’s, yet its diagnosis largely relies on subjective clinical assessments. Thus, this study proposes a systematic, data-driven approach to accurately classify PD p...
OpenEvidence is a popular artificial intelligence (AI) based medical search engine that generates evidence-based answers. It includes a quick search engine method (OE) that takes only seconds to respond, along with a limited number of references. In ...
FOLR3 serves as an important member of the folate metabolic pathway and plays a crucial role in various malignant tumors. However, the expression pattern, diagnostic value, and regulatory mechanism of FOLR3 in endometrial cancer (EC) remain unclear. ...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.